Cargando…

Effects of tumor necrosis factor-α polymorphism on the brain structural changes of the patients with major depressive disorder

Single Nucleotide Polymorphic (SNP) variations of proinflammatory cytokines such as Tumor Necrosis Factor-α (TNF-α) have been reported to be closely associated with the major depressive disorder (MDD). However, it is unclear if proinflammatory genetic burden adversely affects the regional gray matte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Rubai, Wang, Fan, Zhao, Guoqing, Xia, Weiping, Peng, Daihui, Mao, Ruizhi, Xu, Jingjing, Wang, Zuowei, Hong, Wu, Zhang, Chen, Wang, Yong, Su, Yousong, Huang, Jia, Yang, Tao, Wang, Jijun, Chen, Jun, Palaniyappan, Lena, Fang, Yiru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181976/ https://www.ncbi.nlm.nih.gov/pubmed/30310056 http://dx.doi.org/10.1038/s41398-018-0256-x

Ejemplares similares

Abnormal white matter integrity in Chinese young adults with first-episode medication-free anxious depression: a possible neurological biomarker of subtype major depressive disorder
por: Xia, Weiping, et al.
Publicado: (2018)

Probing the clinical and brain structural boundaries of bipolar and major depressive disorder
por: Yang, Tao, et al.
Publicado: (2021)

Variants in the Upstream Region of the Insulin Receptor Substrate-1 Gene Is Associated with Major Depressive Disorder in the Han Chinese Population
por: Wang, Fan, et al.
Publicado: (2020)

Exploring the Effects of Temperament on Gray Matter Volume of Frontal Cortex in Patients with Mood Disorders
por: Yang, Tao, et al.
Publicado: (2021)

Identifying the Subtypes of Major Depressive Disorder Based on Somatic Symptoms: A Longitudinal Study Using Latent Profile Analysis
por: Wu, Xiaohui, et al.
Publicado: (2022)

Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China
por: Zhu, Yuncheng, et al.
Publicado: (2023)

Program of algorithm for pharmacological treatment of major depressive disorder in China: Benefits or not?
por: Zhu, Yuncheng, et al.
Publicado: (2023)

PAID study design on the role of PKC activation in immune/inflammation-related depression: a randomised placebo-controlled trial protocol
por: Guo, Xiaoyun, et al.
Publicado: (2021)

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment
por: Yao, Lin, et al.
Publicado: (2020)

Identification of IL6 as a susceptibility gene for major depressive disorder
por: Zhang, Chen, et al.
Publicado: (2016)

Evaluation of antidepressant polypharmacy and other interventions for treatment-resistant depression
por: PENG, Daihui, et al.
Publicado: (2014)

Gene expression signatures differentiating major depressive disorder from subsyndromal symptomatic depression
por: Hu, Guoqin, et al.
Publicado: (2021)

Biochemical and Endocrine Parameters for the Discrimination and Calibration of Bipolar Disorder or Major Depressive Disorder
por: Zhu, Yuncheng, et al.
Publicado: (2022)

Differential gene expression in patients with subsyndromal symptomatic depression and major depressive disorder
por: Yang, Chengqing, et al.
Publicado: (2017)

Blood-Based Gene Expression Profiles Models for Classification of Subsyndromal Symptomatic Depression and Major Depressive Disorder
por: Yi, Zhenghui, et al.
Publicado: (2012)

Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder
por: Peng, Daihui, et al.
Publicado: (2015)

Correction: Surface Vulnerability of Cerebral Cortex to Major Depressive Disorder
por: Peng, Daihui, et al.
Publicado: (2015)

P300 event-related potentials in patients with different subtypes of depressive disorders
por: Wang, Yun, et al.
Publicado: (2023)

Guidelines Disconcordance in Acute Bipolar Depression: Data from the National Bipolar Mania Pathway Survey (BIPAS) in Mainland China
por: Wang, Zuowei, et al.
Publicado: (2014)

Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis
por: Wang, Zuowei, et al.
Publicado: (2014)

Gene–disease association study of tumor necrosis factor‐α G‐308A gene polymorphism with risk of major depressive disorder: A systematic review and meta‐analysis
por: Wang, Xin, et al.
Publicado: (2020)

Concordance of the treatment patterns for major depressive disorders between the Canadian Network for Mood and Anxiety Treatments (CANMAT) algorithm and real-world practice in China
por: Yang, Lu, et al.
Publicado: (2022)

A Study of Individualized Diagnosis and Treatment for Depression with Atypical Features (iDoT-AFD): study protocol for a randomized clinical trial and prognosis study
por: Zhou, Rubai, et al.
Publicado: (2023)

Are subsyndromal symptomatic depression and major depressive disorder distinct disorders?
por: Yi, Zhenghui, et al.
Publicado: (2012)

Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review
por: Ma, Ke, et al.
Publicado: (2016)

Multimetric structural covariance in first-episode major depressive disorder: a graph theoretical analysis
por: Chen, Chujun, et al.
Publicado: (2022)

TNF-α, IL-6 and hsCRP in patients with melancholic, atypical and anxious depression: an antibody array analysis related to somatic symptoms
por: Liu, Hongmei, et al.
Publicado: (2022)

TPH2 Gene Polymorphisms and Major Depression – A Meta-Analysis
por: Gao, Jin, et al.
Publicado: (2012)

The Developmental and Translational Study on Biomarkers and Clinical Characteristics-based Diagnostic and Therapeutic Identification of Major Depressive Disorder: Study Protocol for a Multicenter Randomized Controlled Trial in China
por: Liu, Xiaohua, et al.
Publicado: (2020)

Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers
por: Hong, Wu, et al.
Publicado: (2016)

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
por: Li, Zezhi, et al.
Publicado: (2021)

Potential mechanisms of non-suicidal self-injury (NSSI) in major depressive disorder: a systematic review
por: Wu, Baichuan, et al.
Publicado: (2023)

Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China
por: Wang, Zuowei, et al.
Publicado: (2014)

A Genetic Susceptibility Mechanism for Major Depression: Combinations of polymorphisms Defined the Risk of Major Depression and Subpopulations
por: Wang, Yanfang, et al.
Publicado: (2015)

Barriers and facilitators to implementing measurement-based care for depression in Shanghai, China: a situational analysis
por: Murphy, Jill K., et al.
Publicado: (2021)

Lower Health Literacy of Mania Than Depression Among Older People: A Random Survey of a Community Healthcare Service Center
por: Huang, Leping, et al.
Publicado: (2021)

A Preliminary Study of Different Treatment Strategies for Anxious Depression
por: Wang, Yun, et al.
Publicado: (2022)

Low tumor necrosis factor‐α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder
por: Sorri, Annamari, et al.
Publicado: (2018)

Tumor Necrosis Factor-α T-857C (rs1799724) Polymorphism and Risk of Cancers: A Meta-Analysis
por: Wang, Ping, et al.
Publicado: (2016)

Disrupted intrinsic functional brain topology in patients with major depressive disorder
por: Yang, Hong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_anvq3hfjvi8dg0s7ua39eq738m